Cargando…
Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome: A case report
RATIONALE: Hypercoagulability and pregnancy morbidity are hallmarks of the antiphospholipid syndrome (APS). Catastrophic antiphospholipid syndrome (CAPS) is a potentially life-threatening omplication of APS, with widespread acute thrombotic microangiopathy (TMA) that can be precipitated by pregnancy...
Autores principales: | Rovere-Querini, Patrizia, Canti, Valentina, Erra, Roberta, Bianchi, Esperia, Slaviero, Giorgio, D’Angelo, Armando, Rosa, Susanna, Candiani, Massimo, Castiglioni, Maria Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200483/ https://www.ncbi.nlm.nih.gov/pubmed/30290624 http://dx.doi.org/10.1097/MD.0000000000012584 |
Ejemplares similares
-
A Case Report of COVID-Associated Catastrophic Antiphospholipid Syndrome Successfully Treated with Eculizumab
por: Chidharla, Anusha, et al.
Publicado: (2021) -
Efficacy of Eculizumab in a Patient With Immunoadsorption-Dependent Catastrophic Antiphospholipid Syndrome: A Case Report
por: Kronbichler, Andreas, et al.
Publicado: (2014) -
Association of genetic variants in the 3′UTR of HLA-G with Recurrent Pregnancy Loss
por: Amodio, Giada, et al.
Publicado: (2016) -
Eculizumab in recalcitrant antiphospholipid antibody syndrome
por: Zapantis, Ekaterini, et al.
Publicado: (2014) -
Eculizumab for refractory thrombosis in antiphospholipid syndrome
por: Hussain, Habiba, et al.
Publicado: (2022)